Advertisement

Topics

Epidemiology & Intervention Research for Tobacco Control

2014-08-27 03:54:38 | BioPortfolio

Summary

To train tobacco control researchers who can work individually and collaboratively to carry out tobacco control research and use the evidence to implement effective interventions that will result in policy and behavioral change.

Description

BACKGROUND:

The low and middle-income countries of the world face a rising threat to public health from the rapidly escalating epidemic of tobacco use. Strong evidence based programs are urgently needed to promote tobacco control. However, few less developed countries have sufficient infrastructure or capacity for tobacco control research, and funding for such research may be unavailable or extremely limited. This study builds on the strong partnerships already established by the Institute for Global Tobacco Control of the Bloomberg School of Public Health and sets out a strategy for enhanced tobacco control research and capacity building in Asia and Latin America.

The study is in response to a Request for Applications titled "International Tobacco and Health Research and Capacity Building Program" released jointly in June, 2001 by the Fogarty International Center, the National Cancer Institute, the National Institute of Child Health and Human Development, the National Institute of Mental Health, the National Institute of Nursing Research, and the National Institute of Drug Abuse.

DESIGN NARRATIVE:

The core elements of the program will include in-depth training of tobacco control leaders in the regions, regional training and policy relevant epidemiologic and intervention research. Established researchers will receive in-depth training at the Johns Hopkins Bloomberg School of Public Health to equip them not only with needed research competencies but also with an understanding of the relationship between tobacco control evidence and effective policy. Regional training workshops will focus on key regional needs and help to establish a network of tobacco control experts within and between countries who can develop and implement collaborative research projects. Research needs will be established through interactions with stakeholder groups and policy makers in each region. For the initial year, research projects are proposed based on research needs identified as policy relevant through prior collaborations. In Brazil, a national survey in 9,000 residents of tobacco use and tobacco related knowledge, attitudes and behavior is proposed in collaboration with the National Cancer Institute. In China, the proposed research effort is a community intervention trial in 800 families, focusing on the creation of smoke free homes with the Chinese Academy of Preventive Medicine. In Mexico, the Institute plans to work with its partner, the National Institute for Public Health, to estimate smoking attributable morbidity and mortality, and associated costs in 1,200 cases and controls.

Study Design

N/A

Conditions

Lung Diseases

Status

Completed

Source

National Heart, Lung, and Blood Institute (NHLBI)

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:54:38-0400

Clinical Trials [1082 Associated Clinical Trials listed on BioPortfolio]

Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases

Interstitial lung diseases (ILD) are a group of diseases affecting the lung interstitium. The lung scarring that occurs in ILD is often irreversible with only mitigating therapy available ...

Biomarker in Lung Diseases

Disease related biomarkers have been established decades ago, e.g. blood glucose for diabetes diagnosis and management. Their discovery has grown dramatically during the past decade and th...

Trefoil Peptides in Lung Diseases

The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucu...

Database of Interstitial Lung Diseases

The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant...

Breath Analysis by Ion Mobility Spectrometry

Recognition of disease specific clusters of volatile organic compounds in patients with different lung diseases, using breath analysis with ion mobility spectrometry. Lung diseases of inte...

PubMed Articles [11360 Associated PubMed Articles listed on BioPortfolio]

Bullous lung diseases as a risk factor for lung cancer: A case report.

A possible association between lung cancer and bullous lung disease has been suggested and recently supported by the results of genetic studies.

Human pulmonary 3D models for translational research.

Lung diseases belong the major causes of death worldwide. Recent innovative methodological developments now allow more and more for the use of primary human tissue and cells to model such diseases. In...

Extracellular matrix in lung development, homeostasis and disease.

The lung's unique extracellular matrix (ECM), while providing structural support for cells, is critical in the regulation of developmental organogenesis, homeostasis and injury-repair responses. The E...

Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.

Lung cancer is one of the deadliest malignancies. The immune checkpoint-blockade (ICB) tumor therapy has led to striking improvement of long-term survival for some lung cancer patients. However, the r...

The Modern Art of Reading Computed Tomography Images of the Lungs: Quantitative CT.

Lung diseases are increasing in prevalence and overall burden worldwide. To stem the tide, more and more national and international guidelines are recommending the use of various diagnostic algorithms...

Medical and Biotech [MESH] Definitions

A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Pathological processes involving any part of the LUNG.

Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

More From BioPortfolio on "Epidemiology & Intervention Research for Tobacco Control"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Searches Linking to this Trial